Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease

Overview of attention for article published in Frontiers in Pharmacology, February 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 74 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 152,911 followers.

RT @SRMicro_papers: Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. by Lichnog C, Klabunde S, Becker E, Fuh F,…

19 Feb 2019

Reply Repost Favourite

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. by Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, Klenske E, Erickson R, Chiu H, Reed C, Chung S, Neufert C, Atreya I, McBride J, Neurath MF, Zundler S https://t.co/e

19 Feb 2019

Reply Repost Favourite

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease https://t.co/5xeCNDiS0F #pharmacology #openaccess

17 Feb 2019

Reply Repost Favourite

RT @_atanas_: Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease https://t.co/DpJ4uF8P9d

14 Feb 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.